ERBB2 and cancer: We also divided cancer samples according to their hormone status, tumor stage, and lymph node involvement, and observed trends towards higher neutrophil cytotoxic activity in samples with HER2− status, earlier stage and low lymph node involvement (Table 1; Supplementary Table 1; Supplementary Table 2).